Published in Law and Health Weekly, December 3rd, 2005
This agreement grants Medtronic rights with respect to certain intellectual property relating to tantalum capacitors in exchange for an initial license fee payable on Medtronic's first U.S. sales and stipulated royalty payments.
The royalty payments are subject to an agreed-upon maximum and may be eliminated if Medtronic purchases a stipulated percentage of their tantalum capacitors from the company. The royalty periods are for 2 initial 5-year contract periods and may be extended if the royalty maximum is not met as long as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.